Page last updated: 2024-08-23

epirubicin and Adrenocortical Carcinoma

epirubicin has been researched along with Adrenocortical Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bechter, OE; Bronswijk, MJH; Laenen, A1
Caron, P; Grunenwald, S1

Other Studies

2 other study(ies) available for epirubicin and Adrenocortical Carcinoma

ArticleYear
Clinical presentation, treatment modalities and outcome in patients with adrenocortical carcinoma: A single center experience.
    Neoplasma, 2020, Volume: 67, Issue:1

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Epirubicin; Humans; Mitotane; Retrospective Studies; Taxoids; Treatment Outcome

2020
[Adrenocortical carcinomas: therapeutic advances in 2011].
    Annales d'endocrinologie, 2011, Volume: 72 Suppl 1

    Topics: Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Humans; Mitotane; Protein Kinase Inhibitors; Taxoids; Treatment Outcome

2011